Citations 1
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Somaiah, Neeta , Chawla, Sant P. , Block, Matthew S. , Morris, John C. , Kim, Joseph W. , Druta, Mihaela , Sankhala, Kamalesh K. , Hwu, Patrick , Jones, Robin L. , Gnjatic, Sacha , Tuballes, Kevin , Yishak, Mahlet, Yakovich, Adam J., Meulen, Jan ter , Chen, Michael , Bohac, Chet, Gnjatic, Sacha , Jones, Robin L , Khanh, T. , Kim-Schulze, Seunghee , Lu, Hailing , Kenney, Richard T , Pollack, Seth M.
OncoImmunology | November 19, 2020 | Volume: 9 | Issue: 1 | Pages: No page available
